Evidence map›Paper›PMID 41761273›Full record

ArticleBiology direct2026

TDP-43-driven alternative splicing of UQCRC2 modulates mitochondrial bioenergetics.

Xia Xue, Jingwen Hou, Zhiqi Zhang, Zeting Yang, Le Chang, Zengguang Yang, Simeng Liu, Huang Huang, Lu Mei, Yang Mi and 2 more

Abstract read
In one paragraph

Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xia Xue *Henan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China.
Jingwen Hou *Henan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China.
Zhiqi ZhangHenan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China.
Zeting YangThe First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471000, China.
Le ChangHenan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China.
Zengguang YangHenan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China.
Simeng LiuHenan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China.
Huang HuangDepartment of Gastroenterology, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
Lu MeiDepartment of Gastroenterology, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
Yang MiHenan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China.
Pengyuan ZhengHenan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China. pyzheng@zzu.edu.cn.
Xiangdong SunHenan Key Laboratory for Helicobacter Pylori and Digestive Tract Microecology, The Fifth Affiliated Hospital of Zhengzhou University, Henan Academy of Innovations in Medical Science, State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Zhengzhou, Henan, 450000, China. sunxd7232@zzu.edu.cn.

Funding

Henan AIMS Professional Development Fund JBKY250318Henan Province's Science and Technology Research and Development 252102310238Youth Cultivation Fund of the Fifth Affiliated Hospital of Zhengzhou University YQ2024006
6 · The paper itself

Abstract

TAR DNA-binding protein 43 (TDP-43) is a nuclear RNA-binding protein. It has emerged as a key regulator of RNA processing, such as alternative splicing events, which are essential for cellular homeostasis. The mislocalization and aggregation of TDP-43 are closely associated with mitochondrial dysfunction. However, the mechanisms by which the formation TDP-43 contributes to mitochondrial impairment remain poorly understood. In this study, we confirmed that the TDP-43 loss leads to dramatic alterations in mitochondrial morphology and a significant reduction in respiratory capacity. Further analysis of oxidative phosphorylation (OXPHOS) complex assembly revealed a selective disruption of complex III activity. Notably, the core complex III subunit UQCRC2 was significantly decreased as long as TDP-43 was knocked down. The transcript analysis showed that the loss of TDP-43 results in aberrant alternative splicing of the nuclear-encoded UQCRC2 transcript. In parallel, this mis-splicing event was consistently observed in both dividing cells, including HEK293T, and in the neuroblastoma cell line SH-SY5Y, suggesting that TDP-43-mediated regulation of UQCRC2 splicing can be potentially conserved across a wide range of cell types. These findings indicate a novel role for TDP-43 in maintaining mitochondrial integrity via regulation of UQCRC2 expression and splicing, providing mechanistic insight into how dysregulated RNA processing contributes to mitochondrial bioenergetic deficits.

Indexed as

Alternative SplicingDNA-Binding ProteinsElectron Transport Complex IIIEnergy MetabolismMitochondriaHEK293 CellsHumansOxidative PhosphorylationDNA-Binding ProteinsElectron Transport Complex IIITARDBP protein, humanComplex IIICryptic splicingOxidative phosphorylationTDP-43UQCRC2

Identifiers

PMID41761273
PMCPMC13049743

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.